DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 937 filers reported holding DANAHER CORPORATION in Q4 2014. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $23,388,000 | -0.3% | 162,044 | -1.3% | 0.21% | 0.0% |
| Q2 2019 | $23,454,000 | +5.4% | 164,106 | -2.6% | 0.21% | -0.5% |
| Q1 2019 | $22,248,000 | +25.6% | 168,520 | -1.9% | 0.22% | +9.7% |
| Q4 2018 | $17,709,000 | -6.3% | 171,746 | -1.2% | 0.20% | +5.4% |
| Q3 2018 | $18,896,000 | +17.2% | 173,904 | +6.4% | 0.19% | +8.1% |
| Q2 2018 | $16,123,000 | -1.2% | 163,390 | -2.0% | 0.17% | -7.0% |
| Q1 2018 | $16,321,000 | +126.8% | 166,705 | +115.0% | 0.18% | +98.9% |
| Q4 2017 | $7,197,000 | +8.7% | 77,541 | +0.4% | 0.09% | +3.3% |
| Q3 2017 | $6,622,000 | +307.0% | 77,202 | +300.4% | 0.09% | +275.0% |
| Q2 2017 | $1,627,000 | +9.2% | 19,283 | +10.7% | 0.02% | +20.0% |
| Q1 2017 | $1,490,000 | -18.0% | 17,425 | -24.9% | 0.02% | -23.1% |
| Q4 2016 | $1,818,000 | 0.0% | 23,195 | 0.0% | 0.03% | -3.7% |
| Q3 2016 | $1,818,000 | -17.8% | 23,195 | +5.8% | 0.03% | -20.6% |
| Q2 2016 | $2,213,000 | +4.0% | 21,918 | -2.3% | 0.03% | -2.9% |
| Q1 2016 | $2,128,000 | -0.9% | 22,440 | -2.9% | 0.04% | -22.2% |
| Q4 2015 | $2,147,000 | +1.8% | 23,116 | -6.6% | 0.04% | -2.2% |
| Q3 2015 | $2,109,000 | -2.9% | 24,759 | -2.4% | 0.05% | 0.0% |
| Q2 2015 | $2,172,000 | -89.8% | 25,378 | +1.6% | 0.05% | 0.0% |
| Q1 2015 | $21,200,000 | -10.0% | 24,971 | -9.2% | 0.05% | -13.2% |
| Q4 2014 | $23,561,000 | +10.1% | 27,490 | -2.4% | 0.05% | +6.0% |
| Q3 2014 | $21,394,000 | -13.8% | 28,158 | -10.7% | 0.05% | -15.3% |
| Q2 2014 | $24,831,000 | +27.4% | 31,540 | +21.4% | 0.06% | +18.0% |
| Q1 2014 | $19,485,000 | +3.4% | 25,980 | +6.5% | 0.05% | -3.8% |
| Q4 2013 | $18,837,000 | +22.7% | 24,400 | +10.2% | 0.05% | +8.3% |
| Q3 2013 | $15,349,000 | +19.6% | 22,143 | +9.2% | 0.05% | +14.3% |
| Q2 2013 | $12,832,000 | – | 20,272 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |